https://www.thebiointel.com/ 2026-03-16T23:35:27.413Z daily 1 https://www.thebiointel.com/about 2026-03-16T23:35:27.413Z monthly 0.8 https://www.thebiointel.com/privacy 2026-03-16T23:35:27.413Z yearly 0.3 https://www.thebiointel.com/ai-drug-discovery 2026-03-16T23:35:27.943Z daily 0.9 https://www.thebiointel.com/biopharma-industry 2026-03-16T23:35:27.943Z daily 0.9 https://www.thebiointel.com/biotech-innovation 2026-03-16T23:35:27.943Z daily 0.9 https://www.thebiointel.com/healthcare-investment 2026-03-16T23:35:27.943Z daily 0.9 https://www.thebiointel.com/medical-technology 2026-03-16T23:35:27.943Z daily 0.9 https://www.thebiointel.com/regulatory-policy 2026-03-16T23:35:27.943Z daily 0.9 https://www.thebiointel.com/article/oasys-health-secures-funding-expand-ai-health-platform 2026-01-11T20:01:59.228Z weekly 0.8 https://www.thebiointel.com/article/richard-pazdur-warns-political-chaos-damaging-fda 2026-01-13T08:01:57.843Z weekly 0.8 https://www.thebiointel.com/article/abbvie-amgen-lilly-fda-update-post-approval-change-rules 2026-01-13T08:01:57.843Z weekly 0.8 https://www.thebiointel.com/article/novartis-strategic-stance-foregoing-glp1-crowded-market 2026-01-14T02:01:38.445Z weekly 0.8 https://www.thebiointel.com/article/fullscript-oura-collaboration-wearable-data-clinical-workflows 2026-01-14T02:01:38.445Z weekly 0.8 https://www.thebiointel.com/article/fda-revises-safety-labeling-glp1-weight-loss-suicide-warnings-removed 2026-01-14T14:02:02.202Z weekly 0.8 https://www.thebiointel.com/article/jpm26-sanofi-strategy-vaccine-sector-volatility 2026-01-14T20:01:37.453Z weekly 0.8 https://www.thebiointel.com/article/telehealth-companies-race-to-offer-oral-wegovy-pill 2026-01-06T16:03:45.285Z weekly 0.8 https://www.thebiointel.com/article/anthropic-openai-healthcare-comparison 2026-01-12T02:02:09.007Z weekly 0.8 https://www.thebiointel.com/article/alnylam-ambitious-five-year-plan-2026 2026-01-12T02:02:09.007Z weekly 0.8 https://www.thebiointel.com/article/sarepta-therapeutics-catalyst-rich-2026-si-rna-opportunities 2026-01-13T14:02:09.118Z weekly 0.8 https://www.thebiointel.com/article/pfizer-fast-tracks-obesity-programs-race-patent-cliff 2026-01-13T14:02:09.118Z weekly 0.8 https://www.thebiointel.com/article/patient-empathy-scalability-overburdened-healthcare 2026-01-06T16:03:45.285Z weekly 0.8 https://www.thebiointel.com/article/ama-calls-for-permanent-medicare-telehealth-services 2026-01-06T16:03:45.285Z weekly 0.8 https://www.thebiointel.com/article/telehealth-providers-expand-access-wegovy-obesity-pill 2026-01-06T23:28:36.253Z weekly 0.8 https://www.thebiointel.com/article/fda-rejects-sanofi-ms-drug-safety-efficacy-concerns 2026-01-06T16:03:45.285Z weekly 0.8 https://www.thebiointel.com/article/bristol-myers-squibb-early-stage-bets-amid-pharma-late-stage-frenzy 2026-01-13T00:06:30.870Z weekly 0.8 https://www.thebiointel.com/article/fda-eases-oversight-wearables-ai-devices 2026-01-06T21:15:13.923Z weekly 0.8 https://www.thebiointel.com/article/federal-health-officials-slash-childhood-vaccine-recommendations 2026-01-06T21:54:40.639Z weekly 0.8 https://www.thebiointel.com/article/sanofi-ms-drug-fda-setback-safety-efficacy 2026-01-06T21:54:40.639Z weekly 0.8 https://www.thebiointel.com/article/telehealth-companies-adopt-wegovy-pill-obesity-market-shift 2026-01-06T21:54:40.639Z weekly 0.8 https://www.thebiointel.com/article/catalio-appoints-ceo-autoimmune-disease-startup 2026-01-06T21:54:40.639Z weekly 0.8 https://www.thebiointel.com/article/nvidia-expands-ai-drug-discovery-partnerships-lilly-thermo-fisher 2026-01-13T00:06:30.870Z weekly 0.8 https://www.thebiointel.com/article/fda-eases-regulation-ai-enabled-wearables-boost-adoption 2026-01-06T23:28:36.253Z weekly 0.8 https://www.thebiointel.com/article/fda-eases-oversight-ai-enabled-devices-wearables 2026-01-06T23:49:17.514Z weekly 0.8 https://www.thebiointel.com/article/arrowhead-pharmaceuticals-gene-silencing-drugs-for-obesity 2026-01-06T23:28:36.253Z weekly 0.8 https://www.thebiointel.com/article/amgen-expands-cancer-portfolio-with-dark-blue-therapeutics-deal 2026-01-07T15:32:48.331Z weekly 0.8 https://www.thebiointel.com/article/nih-crisis-of-integrity-four-leaders-resign 2026-01-11T01:45:11.581Z weekly 0.8 https://www.thebiointel.com/article/abbvie-invests-650m-cancer-drug-rd-bispecific-antibody 2026-01-13T02:01:20.042Z weekly 0.8 https://www.thebiointel.com/article/advances-in-perfusion-technologies-and-organ-transplantation 2026-01-13T20:01:40.381Z weekly 0.8 https://www.thebiointel.com/article/astrazeneca-strategic-route-80b-revenue-2030 2026-01-14T14:02:02.202Z weekly 0.8 https://www.thebiointel.com/article/eli-lilly-advances-autoimmune-pipeline-with-ventyx-biosciences-acquisition 2026-01-07T15:32:48.331Z weekly 0.8 https://www.thebiointel.com/article/us-dietary-guidelines-beef-dairy-industry-ties-debate 2026-01-07T20:02:43.369Z weekly 0.8 https://www.thebiointel.com/article/amgen-dark-blue-therapeutics-aml-acquisition 2026-01-07T20:02:43.369Z weekly 0.8 https://www.thebiointel.com/article/nih-loss-scientific-integrity-leads-to-resignations 2026-01-11T01:48:12.307Z weekly 0.8 https://www.thebiointel.com/article/gsk-functional-cure-chronic-hepatitis-b-bepirovirsen 2026-01-08T02:02:35.368Z weekly 0.8 https://www.thebiointel.com/article/jp-morgan-record-obesity-diabetes-dealmaking-2025 2026-01-08T02:02:35.368Z weekly 0.8 https://www.thebiointel.com/article/fda-eases-regulation-of-wearables-ai-health-devices 2026-01-08T02:02:35.368Z weekly 0.8 https://www.thebiointel.com/article/record-obesity-diabetes-dealmaking-2025 2026-01-08T08:02:32.293Z weekly 0.8 https://www.thebiointel.com/article/fda-eases-regulation-ai-wearables 2026-01-08T08:02:32.293Z weekly 0.8 https://www.thebiointel.com/article/parabilis-305m-funding-cancer-drug-development 2026-01-08T14:02:54.335Z weekly 0.8 https://www.thebiointel.com/article/appeals-court-blocks-340b-pilot-program 2026-01-08T14:02:54.335Z weekly 0.8 https://www.thebiointel.com/article/fda-delays-expedited-submission-request-stoke-therapeutics-severe-epilepsy-drug 2026-01-11T20:01:59.228Z weekly 0.8 https://www.thebiointel.com/article/senators-investigate-unitedhealth-medicare-advantage-nursing-home-practices 2026-01-08T14:02:54.335Z weekly 0.8 https://www.thebiointel.com/article/fentanyl-potency-drop-drug-overdose-deaths-decline 2026-01-08T20:02:26.249Z weekly 0.8 https://www.thebiointel.com/article/openai-chatgpt-health-medical-record-upload 2026-01-08T20:02:26.249Z weekly 0.8 https://www.thebiointel.com/article/house-passes-extension-aca-subsidies-bipartisan-support 2026-01-08T23:20:17.255Z weekly 0.8 https://www.thebiointel.com/article/parabilis-305m-fundraising-cancer-drug-2026 2026-01-08T23:20:17.255Z weekly 0.8 https://www.thebiointel.com/article/eli-lilly-acquires-ventyx-biosciences-1-2b-immunology 2026-01-09T02:02:41.429Z weekly 0.8 https://www.thebiointel.com/article/matt-holt-30-billion-health-tech-consolidation-bet 2026-01-09T02:02:41.429Z weekly 0.8 https://www.thebiointel.com/article/matt-holt-30b-health-tech-thoreau-consolidation 2026-01-09T08:02:38.907Z weekly 0.8 https://www.thebiointel.com/article/medicaid-restrictions-miss-cancer-screenings-study 2026-01-09T08:02:38.907Z weekly 0.8 https://www.thebiointel.com/article/inflarx-layoffs-pipeline-reprioritization 2026-01-09T14:02:39.572Z weekly 0.8 https://www.thebiointel.com/article/insmed-brinsupri-sales-beat-bronchiectasis 2026-01-09T20:02:21.868Z weekly 0.8 https://www.thebiointel.com/article/chatgpt-health-microsoft-missed-opportunity 2026-01-11T02:01:34.500Z weekly 0.8 https://www.thebiointel.com/article/aktis-ipo-radiopharmaceutical-cancer-therapies 2026-01-09T20:02:21.868Z weekly 0.8 https://www.thebiointel.com/article/apella-80m-series-b-hospital-or-optimization 2026-01-10T02:02:24.556Z weekly 0.8 https://www.thebiointel.com/article/pomelo-care-92m-funding-expand-beyond-maternity 2026-01-10T02:02:24.556Z weekly 0.8 https://www.thebiointel.com/article/us-overdose-deaths-decline-2025-insights 2026-01-14T20:01:37.453Z weekly 0.8 https://www.thebiointel.com/article/pharmacy-compounder-antitrust-lawsuit-lilly-novo-weight-loss-market 2026-01-15T02:01:27.996Z weekly 0.8 https://www.thebiointel.com/article/private-equity-healthcare-boom-investment-competition 2026-01-15T02:01:27.996Z weekly 0.8 https://www.thebiointel.com/article/jazz-sells-priority-review-voucher-200m-program-renewal-stalls-senate 2026-01-15T14:01:58.532Z weekly 0.8 https://www.thebiointel.com/article/jpm-day-3-rare-disease-spotlight-2026-key-milestones 2026-01-15T14:01:58.532Z weekly 0.8 https://www.thebiointel.com/article/jpm-2026-day-4-regeneron-ipo-jnj-spotlight 2026-01-15T20:01:31.639Z weekly 0.8 https://www.thebiointel.com/article/kaiser-permanente-settlement-medicare-advantage-fraud 2026-01-16T02:01:42.490Z weekly 0.8 https://www.thebiointel.com/article/takeda-1-2b-bispecific-antibody-oncology-deal 2026-01-16T02:01:42.490Z weekly 0.8 https://www.thebiointel.com/article/a-guide-to-noninvasive-liver-diagnostic-devices-technology-leading-organizations-explained 2026-01-16T08:01:48.302Z weekly 0.8 https://www.thebiointel.com/article/sanofi-takeover-speculation-ocular-therapeutix-stock-soaring 2026-01-16T14:02:22.281Z weekly 0.8 https://www.thebiointel.com/article/novo-nordisk-foundation-850m-investment-denmark-europe-innovation 2026-01-16T14:02:22.281Z weekly 0.8 https://www.thebiointel.com/article/measles-cases-surge-south-carolina-public-health-concerns 2026-01-16T20:02:03.997Z weekly 0.8 https://www.thebiointel.com/article/vedanta-biosciences-workforce-cuts-phase-iii-c-diff-study 2026-01-16T20:02:03.997Z weekly 0.8 https://www.thebiointel.com/article/no-link-tylenol-pregnancy-autism-risk-study 2026-01-17T02:01:51.853Z weekly 0.8 https://www.thebiointel.com/article/behind-new-dietary-guidelines-industry-influence-deadline-pressures 2026-01-17T14:02:29.341Z weekly 0.8 https://www.thebiointel.com/article/ending-universal-rotavirus-vaccination-tragedy-expert-perspective 2026-01-17T14:02:29.341Z weekly 0.8 https://www.thebiointel.com/article/opinion-what-lingers-in-the-pitt-heartache-missing-outrage 2026-01-18T14:02:27.133Z weekly 0.8 https://www.thebiointel.com/article/personal-touch-and-tech-synergy-enhance-member-engagement 2026-01-18T20:01:47.577Z weekly 0.8 https://www.thebiointel.com/article/bridging-diagnostic-gap-allergy-care-comprehensive-testing 2026-01-18T20:01:47.577Z weekly 0.8 https://www.thebiointel.com/article/analyzing-2025-q4-us-life-sciences-job-market 2026-01-19T08:02:42.090Z weekly 0.8 https://www.thebiointel.com/article/regulatory-alignment-biotech-jpm26-fda-challenges 2026-01-19T08:02:42.090Z weekly 0.8 https://www.thebiointel.com/article/2026-ipo-train-agomab-spyglass-nasdaq-debut 2026-01-19T14:02:24.011Z weekly 0.8 https://www.thebiointel.com/article/novo-rises-oral-wegovy-3000-patients-first-week 2026-01-19T14:02:24.011Z weekly 0.8 https://www.thebiointel.com/article/jpm26-galapagos-new-ceo-turn-ship-around 2026-01-19T20:02:00.720Z weekly 0.8 https://www.thebiointel.com/article/congress-revives-bipartisan-health-care-proposal-drug-middlemen 2026-01-20T02:02:29.203Z weekly 0.8 https://www.thebiointel.com/article/arrowhead-pharmaceuticals-promising-fat-loss-gene-silencing-obesity 2026-01-06T16:03:45.285Z weekly 0.8 https://www.thebiointel.com/article/bariatric-surgery-outperforms-glp1-for-type2-diabetes 2026-01-20T02:02:29.203Z weekly 0.8 https://www.thebiointel.com/article/the-new-gold-rush-in-brain-science 2026-01-22T08:02:34.027Z weekly 0.8 https://www.thebiointel.com/article/arrowhead-pharmaceuticals-gene-silencing-drugs-obesity-fat-reduction 2026-01-06T21:54:40.639Z weekly 0.8 https://www.thebiointel.com/article/china-set-to-surpass-us-as-leader-in-biotech-innovation 2026-01-07T15:32:48.331Z weekly 0.8 https://www.thebiointel.com/article/gsk-bepirovirsen-functional-cure-chronic-hepatitis-b 2026-01-07T20:02:43.369Z weekly 0.8 https://www.thebiointel.com/article/gsk-functional-cure-chronic-hepatitis-b 2026-01-08T08:02:32.293Z weekly 0.8 https://www.thebiointel.com/article/gsk-acquires-rapt-therapeutics-immunology-food-allergy 2026-01-21T02:27:19.971Z weekly 0.8 https://www.thebiointel.com/article/alveus-therapeutics-obesity-drug-160m-funding 2026-01-09T02:02:41.429Z weekly 0.8 https://www.thebiointel.com/article/alveus-therapeutics-obesity-drug-startup-160m-funding 2026-01-09T08:02:38.907Z weekly 0.8 https://www.thebiointel.com/article/rampart-bioscience-shutdown-gene-therapy-platform 2026-01-09T14:02:39.572Z weekly 0.8 https://www.thebiointel.com/article/personalized-crispr-medicines-startup-aurora-therapeutics 2026-01-09T14:02:39.572Z weekly 0.8 https://www.thebiointel.com/article/slingshot-ai-withdraws-therapy-chatbot-ash-uk-regulatory-hurdles 2026-01-21T20:02:15.708Z weekly 0.8 https://www.thebiointel.com/article/eric-green-joins-illumina-as-cmo 2026-01-09T20:02:21.868Z weekly 0.8 https://www.thebiointel.com/article/aktis-oncology-318m-ipo-radiopharmaceuticals 2026-01-10T02:02:24.556Z weekly 0.8 https://www.thebiointel.com/article/biomedical-student-enrollment-increases-despite-funding-challenges 2026-01-15T08:01:33.387Z weekly 0.8 https://www.thebiointel.com/article/french-startup-naox-technologies-fda-clearance-in-ear-eeg 2026-01-21T02:27:19.971Z weekly 0.8 https://www.thebiointel.com/article/fda-approves-aidoc-ai-tool-detect-conditions-ct-scans 2026-01-21T14:02:40.945Z weekly 0.8 https://www.thebiointel.com/article/pfizer-exits-hiv-drug-venture-pockets-1-9b-gsk-majority 2026-01-21T20:02:15.708Z weekly 0.8 https://www.thebiointel.com/article/nih-backed-startup-amissa-unveils-ai-platform-to-improve-menopause-care 2026-01-22T08:02:34.027Z weekly 0.8 https://www.thebiointel.com/article/bms-deepens-cancer-drug-portfolio-with-850m-investment-janux-tumor-activated-therapies 2026-01-22T14:02:32.850Z weekly 0.8 https://www.thebiointel.com/article/increasing-competition-biopharma-job-market-industry-concerns 2026-01-22T14:02:32.850Z weekly 0.8 https://www.thebiointel.com/article/measles-outbreak-hospital-financial-challenges-us-healthcare 2026-01-22T20:02:06.930Z weekly 0.8 https://www.thebiointel.com/article/2026-breakout-year-healthcare-ai-bessemer 2026-01-23T02:02:22.166Z weekly 0.8 https://www.thebiointel.com/article/lawmakers-grill-health-insurance-ceos-4-key-takeaways 2026-01-23T08:01:56.828Z weekly 0.8 https://www.thebiointel.com/article/spending-bill-clears-house-priority-review-voucher-hopes-alive 2026-01-23T14:02:25.838Z weekly 0.8 https://www.thebiointel.com/article/chinas-corxel-secures-series-d1-advance-oral-glp-1-therapy 2026-01-23T14:02:25.838Z weekly 0.8 https://www.thebiointel.com/article/hospitals-demand-better-security-patient-record-sharing 2026-01-23T20:02:26.649Z weekly 0.8 https://www.thebiointel.com/article/kaiser-permanente-workers-strike-2026 2026-01-24T02:02:21.552Z weekly 0.8 https://www.thebiointel.com/article/alkermes-narcolepsy-orexin-agonist-fatigue-therapies 2026-01-24T02:02:21.552Z weekly 0.8 https://www.thebiointel.com/article/cdc-pauses-public-health-infrastructure-grants 2026-01-24T20:02:21.975Z weekly 0.8 https://www.thebiointel.com/article/powdered-whole-milk-implicated-byheart-botulism-outbreak 2026-01-24T20:02:21.975Z weekly 0.8 https://www.thebiointel.com/article/openai-anthropic-healthcare-push-industry-impact 2026-01-25T20:02:22.895Z weekly 0.8 https://www.thebiointel.com/article/answersnow-raises-40m-expand-autism-therapy-access 2026-01-25T20:02:22.895Z weekly 0.8 https://www.thebiointel.com/article/rare-disease-biotechs-4b-loss-priority-voucher-program 2026-01-26T08:02:43.988Z weekly 0.8 https://www.thebiointel.com/article/rethinking-rare-disease-progress-sandbox-approach 2026-01-26T08:02:43.988Z weekly 0.8 https://www.thebiointel.com/article/fda-plausible-mechanism-pathway-gene-editing-concerns 2026-01-26T14:02:32.680Z weekly 0.8 https://www.thebiointel.com/article/endometriosis-biotech-diagnostic-test-innovations 2026-01-26T14:02:32.680Z weekly 0.8 https://www.thebiointel.com/article/revolution-evaluates-market-value-merck-steps-back-temporarily 2026-01-26T20:02:15.557Z weekly 0.8 https://www.thebiointel.com/article/remembering-alex-pretti-minneapolis-nurse-honored-healthcare-community 2026-01-26T20:02:15.557Z weekly 0.8 https://www.thebiointel.com/article/implementing-performance-based-contracting-digital-health-solutions 2026-01-27T02:02:21.160Z weekly 0.8 https://www.thebiointel.com/article/multi-cancer-early-detection-endeavor-health-cancerguard-study 2026-01-27T02:02:21.160Z weekly 0.8 https://www.thebiointel.com/article/fda-inspections-redefining-stress-readiness-pharma-industry 2026-01-27T08:02:21.524Z weekly 0.8 https://www.thebiointel.com/article/big-pharma-api-stockpile-deals-confidentiality-public-interest 2026-01-27T08:02:21.524Z weekly 0.8 https://www.thebiointel.com/article/syphilis-cases-surge-among-pregnant-people-public-health-challenges 2026-01-27T14:02:44.284Z weekly 0.8 https://www.thebiointel.com/article/baseline-therapeutics-challenges-lilly-in-alcohol-use-disorder 2026-01-27T14:02:44.284Z weekly 0.8 https://www.thebiointel.com/article/new-drugs-medicare-price-negotiations-expanding-efforts-2026 2026-01-28T02:02:11.906Z weekly 0.8 https://www.thebiointel.com/article/2026-us-life-sciences-employment-outlook-biopharma-workforce-crossroads 2026-01-28T08:02:42.432Z weekly 0.8 https://www.thebiointel.com/article/roche-obesity-drug-ct-388-phase-2-results-and-2026-outlook 2026-01-28T08:02:42.432Z weekly 0.8 https://www.thebiointel.com/article/jjs-darzalex-faspro-multiple-myeloma-frontline-indication 2026-01-28T14:02:05.937Z weekly 0.8 https://www.thebiointel.com/article/nocd-launches-parent-brand-noto-acquires-ptsd-provider-rebound-health 2026-01-29T02:02:15.118Z weekly 0.8 https://www.thebiointel.com/article/climatic-emerges-10m-funding-preventive-daily-lung-health-category 2026-01-29T02:02:15.118Z weekly 0.8 https://www.thebiointel.com/article/astrazeneca-expands-15b-chinese-investments-cell-therapies-radiopharma 2026-01-29T14:02:24.316Z weekly 0.8 https://www.thebiointel.com/article/sanofi-sales-dip-public-health-vaccines-challenges 2026-01-29T14:02:24.316Z weekly 0.8 https://www.thebiointel.com/article/genes-influence-human-lifespan-more-than-thought 2026-01-29T20:02:16.778Z weekly 0.8 https://www.thebiointel.com/article/tenpoint-presbyopia-eye-drop-fda-approval-financing 2026-01-29T20:02:16.778Z weekly 0.8 https://www.thebiointel.com/article/trumps-addiction-initiative-bold-vision-sparse-details 2026-01-30T02:02:33.731Z weekly 0.8 https://www.thebiointel.com/article/epic-vs-health-gorilla-battle-medical-record-control 2026-01-30T02:02:33.731Z weekly 0.8 https://www.thebiointel.com/article/maven-clinic-new-research-institute-digital-care 2026-01-30T08:02:16.254Z weekly 0.8 https://www.thebiointel.com/article/trumprx-launch-delayed-amid-anti-kickback-concerns 2026-01-30T14:02:22.746Z weekly 0.8 https://www.thebiointel.com/article/summit-potential-keytruda-rival-fda-decision-november 2026-01-30T14:02:22.746Z weekly 0.8 https://www.thebiointel.com/article/astrazeneca-expands-metabolic-disease-portfolio-cspc-partnership 2026-01-30T20:01:37.904Z weekly 0.8 https://www.thebiointel.com/article/senate-spending-bill-collapse-affects-rare-pediatric-disease-voucher-program 2026-01-30T20:01:37.904Z weekly 0.8 https://www.thebiointel.com/article/healthcare-moves-january-executive-changes-layoffs 2026-01-31T02:01:28.175Z weekly 0.8 https://www.thebiointel.com/article/four-health-tech-funding-announcements-january 2026-01-31T02:01:28.175Z weekly 0.8 https://www.thebiointel.com/article/fda-new-guidance-multiple-myeloma-decade-progress 2026-01-31T14:01:19.484Z weekly 0.8 https://www.thebiointel.com/article/opinion-crucial-role-shared-decision-making-healthcare 2026-01-31T20:01:04.107Z weekly 0.8 https://www.thebiointel.com/article/tenpoint-therapeutics-fda-approval-yuvezzi-presbyopia-treatment 2026-02-01T02:01:27.734Z weekly 0.8 https://www.thebiointel.com/article/clinical-trial-hold-regenxbio-gene-therapy-rare-disease 2026-02-01T14:01:11.779Z weekly 0.8 https://www.thebiointel.com/article/premise-crossover-merger-new-employer-health-model 2026-02-01T20:01:15.104Z weekly 0.8 https://www.thebiointel.com/article/sanofi-advances-treatment-neurological-symptoms-rare-disease 2026-02-02T08:01:45.527Z weekly 0.8 https://www.thebiointel.com/article/movement-toward-pricing-transparency-pharmaceutical-industry 2026-02-02T08:01:45.527Z weekly 0.8 https://www.thebiointel.com/article/fda-launches-precheck-program-strengthening-manufacturer-collaboration 2026-02-02T14:01:44.668Z weekly 0.8 https://www.thebiointel.com/article/emerging-interest-in-male-birth-control-clinical-trials 2026-02-02T14:01:44.668Z weekly 0.8 https://www.thebiointel.com/article/unitedhealth-earnings-forecast-medicare-advantage-market-shift 2026-02-02T20:01:28.880Z weekly 0.8 https://www.thebiointel.com/article/whys-womens-health-scalable-sector-healthcare 2026-02-02T20:01:28.880Z weekly 0.8 https://www.thebiointel.com/article/understanding-dextrocardia-catherine-oharas-rare-heart-condition 2026-02-03T02:01:37.937Z weekly 0.8 https://www.thebiointel.com/article/biotech-resilience-four-companies-advancing-to-ipo-amid-government-shutdown 2026-02-03T02:01:37.937Z weekly 0.8 https://www.thebiointel.com/article/biontech-multi-modality-play-outpaces-moderna-mrna-focused-pipeline 2026-02-03T08:01:31.207Z weekly 0.8 https://www.thebiointel.com/article/amgen-lilly-recommit-puerto-rico-manufacturing-momentum 2026-02-03T08:01:31.207Z weekly 0.8 https://www.thebiointel.com/article/pfizer-advances-monthly-obesity-drug-amid-competition 2026-02-03T14:01:44.053Z weekly 0.8 https://www.thebiointel.com/article/measles-outbreak-ice-detention-facilities 2026-02-03T14:01:44.053Z weekly 0.8 https://www.thebiointel.com/article/pfizer-early-metsera-data-analysts-want-more 2026-02-03T20:01:23.057Z weekly 0.8 https://www.thebiointel.com/article/novo-nordisk-lower-sales-profits-obesity-drug-competition 2026-02-03T20:01:23.057Z weekly 0.8 https://www.thebiointel.com/article/rare-pediatric-disease-vouchers-pbm-reform-spending-bill 2026-02-04T02:01:57.199Z weekly 0.8 https://www.thebiointel.com/article/alaffia-health-55m-ai-healthcare-waste-reduction 2026-02-04T02:01:57.199Z weekly 0.8 https://www.thebiointel.com/article/2021-banner-year-biotech-ipos-current-status 2026-02-04T08:01:29.861Z weekly 0.8 https://www.thebiointel.com/article/amgen-stands-firm-on-tavneos-amid-fda-request-for-withdrawal 2026-02-04T14:01:46.120Z weekly 0.8 https://www.thebiointel.com/article/gsk-shifts-focus-from-glp-1s-to-addressing-obesitys-downstream-effects 2026-02-04T14:01:46.120Z weekly 0.8 https://www.thebiointel.com/article/epic-systems-launches-ai-charting-ambient-scribe-market 2026-02-04T20:01:33.616Z weekly 0.8 https://www.thebiointel.com/article/dexcom-ceo-cgms-for-diabetics-on-glp1 2026-02-05T08:02:02.832Z weekly 0.8 https://www.thebiointel.com/article/veradermics-ipo-oral-minoxidil-hair-loss-pivotal-tests 2026-02-05T08:02:02.832Z weekly 0.8 https://www.thebiointel.com/article/novartis-refines-oncology-pipeline-cuts-6-early-cancer-candidates 2026-02-05T14:01:35.605Z weekly 0.8 https://www.thebiointel.com/article/primegen-spac-route-to-nasdaq-stem-cell-therapeutics 2026-02-05T14:01:35.605Z weekly 0.8 https://www.thebiointel.com/article/digital-health-ma-wave-accelerates-2026 2026-02-06T02:01:18.662Z weekly 0.8 https://www.thebiointel.com/article/trumprx-launch-prescription-drug-platform-market-impact 2026-02-06T08:01:20.247Z weekly 0.8 https://www.thebiointel.com/article/eikon-therapeutics-ipo-biopharma-rebound 2026-02-06T14:01:51.721Z weekly 0.8 https://www.thebiointel.com/article/hims-hers-compounded-wegovy-pill-controversy 2026-02-06T14:01:51.721Z weekly 0.8 https://www.thebiointel.com/article/arpa-h-restructures-layoffs-impact-biomedical-commercialization-staff 2026-02-06T20:01:28.537Z weekly 0.8 https://www.thebiointel.com/article/biogens-strategic-push-crowded-phase-3-pipeline-counter-generic-pressures 2026-02-06T20:01:28.537Z weekly 0.8 https://www.thebiointel.com/article/hhs-scrapping-340b-rebate-program-benefits-providers 2026-02-07T02:01:07.768Z weekly 0.8 https://www.thebiointel.com/article/ethical-debate-gender-affirming-care-minors-hhs-report 2026-02-07T14:01:41.438Z weekly 0.8 https://www.thebiointel.com/article/critique-nflpa-funded-cte-study-football-players 2026-02-07T14:01:41.438Z weekly 0.8 https://www.thebiointel.com/article/clinical-trial-success-roivant-rare-disease-drug-pfizer 2026-02-08T20:01:26.394Z weekly 0.8 https://www.thebiointel.com/article/employers-celebrate-pbm-reform-complex-realities 2026-02-08T20:01:26.394Z weekly 0.8 https://www.thebiointel.com/article/2025-reshaped-the-fda-what-will-2026-hold 2026-02-09T08:01:12.473Z weekly 0.8 https://www.thebiointel.com/article/novo-nordisk-sues-hims-hers-over-compounded-oral-wegovy-pill 2026-02-09T14:01:35.065Z weekly 0.8 https://www.thebiointel.com/article/genentech-141-more-layoffs-2025 2026-02-09T14:01:35.065Z weekly 0.8 https://www.thebiointel.com/article/eli-lilly-expands-in-vivo-cell-therapy-acquisition-orna-therapeutics 2026-02-10T02:01:39.702Z weekly 0.8 https://www.thebiointel.com/article/fda-rejects-regenxbio-rare-disease-gene-therapy 2026-02-10T02:01:39.702Z weekly 0.8 https://www.thebiointel.com/article/fda-warning-hims-hers-compounding-pharmacy-violations 2026-02-10T14:01:40.346Z weekly 0.8 https://www.thebiointel.com/article/solace-health-achieves-unicorn-status-revolutionizing-care-navigation 2026-02-10T20:01:13.598Z weekly 0.8 https://www.thebiointel.com/article/fda-refuses-review-moderna-influenza-vaccine 2026-02-11T02:01:22.232Z weekly 0.8 https://www.thebiointel.com/article/evommune-challenges-dupixent-atopic-dermatitis 2026-02-11T02:01:22.232Z weekly 0.8 https://www.thebiointel.com/article/pelage-advances-hair-loss-treatment-science-breakthrough 2026-02-11T08:01:37.204Z weekly 0.8 https://www.thebiointel.com/article/ai-growing-impact-pharma-bottom-line-beyond-drug-discovery 2026-02-11T08:01:37.204Z weekly 0.8 https://www.thebiointel.com/article/pharmaessentia-bolsters-us-supply-chain-puerto-rico-investment 2026-02-11T14:01:15.717Z weekly 0.8 https://www.thebiointel.com/article/medicaid-funding-cuts-political-urban-rural-division 2026-02-11T20:01:26.889Z weekly 0.8 https://www.thebiointel.com/article/mount-sinai-selects-microsoft-dragon-copilot-ambient-clinical-documentation 2026-02-12T02:01:08.335Z weekly 0.8 https://www.thebiointel.com/article/7-key-insights-2026-biopharma-job-market-hiring-landscape 2026-02-12T08:01:59.879Z weekly 0.8 https://www.thebiointel.com/article/sanofi-change-leadership-paul-hudson-steps-down 2026-02-12T08:01:59.879Z weekly 0.8 https://www.thebiointel.com/article/big-funding-digital-mental-health-talkiatry-big-health 2026-02-12T14:01:13.949Z weekly 0.8 https://www.thebiointel.com/article/bridgebio-infigratinib-phase-3-achondroplasia-treatment 2026-02-12T20:01:26.254Z weekly 0.8 https://www.thebiointel.com/article/modernas-mrna-flu-vaccine-faces-fda-review-setback 2026-02-13T08:01:48.930Z weekly 0.8 https://www.thebiointel.com/article/mayo-clinic-platform-challenges-of-de-identified-data-utility 2026-02-13T08:01:48.930Z weekly 0.8 https://www.thebiointel.com/article/eli-lilly-gears-up-orforglipron-approval-novo-wegovy-expansion 2026-02-13T14:01:19.026Z weekly 0.8 https://www.thebiointel.com/article/ptc-therapeutics-withdraws-fda-approval-bid-for-duchenne-treatment 2026-02-13T20:01:18.426Z weekly 0.8 https://www.thebiointel.com/article/anterior-secures-40m-to-revolutionize-care-approvals-ai-automation 2026-02-14T08:02:42.910Z weekly 0.8 https://www.thebiointel.com/article/vertex-crispr-ambitious-goals-casgevy-gene-therapy-patient-access 2026-02-14T08:02:42.910Z weekly 0.8 https://www.thebiointel.com/article/pediatricians-challenge-rfk-jr-hhs-vaccine-policy-legal-battle 2026-02-14T20:02:06.775Z weekly 0.8 https://www.thebiointel.com/article/fda-rejects-disc-medicine-rare-disease-therapy 2026-02-15T02:01:54.863Z weekly 0.8 https://www.thebiointel.com/article/2026-turning-point-american-innovation 2026-02-16T08:02:27.416Z weekly 0.8 https://www.thebiointel.com/article/leadership-void-at-cdc-amid-turmoil 2026-02-15T20:01:58.337Z weekly 0.8 https://www.thebiointel.com/article/rural-care-crisis-economic-challenge-2026 2026-02-23T08:02:32.941Z weekly 0.8 https://www.thebiointel.com/article/dia-helping-regulators-turn-ai-principles-into-everyday-review 2026-02-16T08:02:27.416Z weekly 0.8 https://www.thebiointel.com/article/medicare-advantage-growth-declines-second-year 2026-02-16T20:02:01.968Z weekly 0.8 https://www.thebiointel.com/article/biopharma-fetal-bovine-serum-shortage-drug-development 2026-02-17T08:02:43.387Z weekly 0.8 https://www.thebiointel.com/article/moderna-mrna-flu-vaccine-regulatory-challenges 2026-02-17T08:02:43.387Z weekly 0.8 https://www.thebiointel.com/article/disc-medicine-regulatory-comeback-bitopertin-old-fda-leadership-challenges 2026-02-17T20:02:22.968Z weekly 0.8 https://www.thebiointel.com/article/compass-pathways-psilocybin-medicine-severe-depression-promise 2026-02-17T20:02:22.968Z weekly 0.8 https://www.thebiointel.com/article/bayer-roundup-7-billion-settlement-cancer-lawsuits 2026-02-18T02:02:22.127Z weekly 0.8 https://www.thebiointel.com/article/ocular-therapeutix-axpaxli-surpasses-eylea-wet-amd-phase-3-trial 2026-02-18T02:02:22.127Z weekly 0.8 https://www.thebiointel.com/article/early-stage-biotech-funding-declines-2025-vc-risk-aversion 2026-02-18T08:02:22.788Z weekly 0.8 https://www.thebiointel.com/article/ionis-pharmaceuticals-tryngolza-launch-2025-shift 2026-02-18T08:02:22.788Z weekly 0.8 https://www.thebiointel.com/article/korsana-biosciences-alzheimers-next-gen-antibody-150m-funding 2026-02-18T14:02:15.145Z weekly 0.8 https://www.thebiointel.com/article/jay-bhattacharya-acting-cdc-chief-implications-public-health-leadership 2026-02-18T20:02:15.584Z weekly 0.8 https://www.thebiointel.com/article/solera-health-launches-comprehensive-behavioral-health-network 2026-02-19T02:02:11.940Z weekly 0.8 https://www.thebiointel.com/article/extending-scientific-rigor-from-bench-to-boardroom 2026-02-19T08:02:12.565Z weekly 0.8 https://www.thebiointel.com/article/cms-national-provider-directory-launch-healthcare-navigation 2026-02-19T20:02:29.086Z weekly 0.8 https://www.thebiointel.com/article/redefining-obesity-treatment-beyond-glp-1-limitations 2026-02-19T20:02:29.086Z weekly 0.8 https://www.thebiointel.com/article/frist-cressey-ventures-425m-healthcare-fund-ai-innovation 2026-02-20T02:02:16.052Z weekly 0.8 https://www.thebiointel.com/article/danaher-10b-acquisition-masimo-diagnostics-acute-care 2026-02-20T02:02:16.052Z weekly 0.8 https://www.thebiointel.com/article/texas-attorney-general-sues-sanofi-over-alleged-kickbacks 2026-02-20T08:02:21.643Z weekly 0.8 https://www.thebiointel.com/article/fda-tracy-beth-hoeg-safety-probes-antidepressants-rsv-antibodies 2026-02-20T14:02:46.419Z weekly 0.8 https://www.thebiointel.com/article/rainfall-health-raises-15m-hospitals-navigate-cms-model 2026-02-20T20:02:26.674Z weekly 0.8 https://www.thebiointel.com/article/makary-prasad-under-fire-fda-turmoil-reaches-president-trump 2026-02-20T20:02:26.674Z weekly 0.8 https://www.thebiointel.com/article/arintra-ai-medical-coding-boosts-mercyhealth-revenue 2026-02-21T02:02:23.786Z weekly 0.8 https://www.thebiointel.com/article/nature-medicine-investigates-morning-immunotherapy-study 2026-02-21T02:02:23.786Z weekly 0.8 https://www.thebiointel.com/article/ai-transforming-nursing-education-elevating-expectations-new-graduates 2026-02-22T14:02:08.112Z weekly 0.8 https://www.thebiointel.com/article/hims-hers-acquisition-eucalyptus-strategic-analysis 2026-02-22T20:02:58.972Z weekly 0.8 https://www.thebiointel.com/article/korsana-biosciences-brain-penetrating-alzheimers-drug 2026-02-22T20:02:58.972Z weekly 0.8 https://www.thebiointel.com/article/sickle-cell-gene-therapies-market-challenges-2026 2026-02-23T08:02:32.941Z weekly 0.8 https://www.thebiointel.com/article/novo-nordisk-cagrisema-falls-short-lilly-zepbound-obesity-trial 2026-02-23T14:02:50.929Z weekly 0.8 https://www.thebiointel.com/article/vanda-fda-approval-bipolar-schizophrenia-bysanti 2026-02-23T14:02:50.929Z weekly 0.8 https://www.thebiointel.com/article/gilead-sciences-acquires-arcellx-multiple-myeloma-therapy 2026-02-23T20:02:23.455Z weekly 0.8 https://www.thebiointel.com/article/bayer-sues-johnson-johnson-prostate-cancer-treatment-advertising-claims 2026-02-23T20:02:23.455Z weekly 0.8 https://www.thebiointel.com/article/cutting-down-oncology-drug-waste-through-improved-forecasting 2026-02-24T08:02:03.481Z weekly 0.8 https://www.thebiointel.com/article/novo-nordisk-price-reduction-obesity-drugs-impact-patients-access 2026-02-24T20:01:34.123Z weekly 0.8 https://www.thebiointel.com/article/slate-medicines-130m-funding-novel-pacap-migraine-drug 2026-02-24T20:01:34.123Z weekly 0.8 https://www.thebiointel.com/article/coral-care-13m-funding-in-home-pediatric-therapy 2026-02-25T02:01:32.816Z weekly 0.8 https://www.thebiointel.com/article/how-lb-rode-brutal-capital-markets-to-successful-ipo-2025 2026-02-25T08:03:04.967Z weekly 0.8 https://www.thebiointel.com/article/balancing-safety-access-rare-disease-lessons-sarepta 2026-02-25T08:03:04.967Z weekly 0.8 https://www.thebiointel.com/article/novo-nordisk-partners-vivtex-oral-obesity-diabetes-treatments 2026-02-25T14:03:25.386Z weekly 0.8 https://www.thebiointel.com/article/mayo-clinic-merck-ai-patient-prognosis-collaboration 2026-02-25T14:03:25.386Z weekly 0.8 https://www.thebiointel.com/article/rising-trend-contract-work-biopharma 2026-02-26T08:02:10.822Z weekly 0.8 https://www.thebiointel.com/article/navigating-fda-turmoil-election-intrigue-ai-healthcare 2026-02-26T20:02:24.154Z weekly 0.8 https://www.thebiointel.com/article/boehringer-ingelheim-sitryx-oral-small-molecules-immunology 2026-02-26T20:02:24.154Z weekly 0.8 https://www.thebiointel.com/article/how-elevance-health-uses-ai-in-healthcare-operations 2026-02-27T02:02:11.334Z weekly 0.8 https://www.thebiointel.com/article/fda-voucher-accelerates-boehringer-hernexeos-approval-lung-cancer 2026-02-27T02:02:11.334Z weekly 0.8 https://www.thebiointel.com/article/deep-dive-jpm26-biospace-insights-san-francisco 2026-02-27T08:02:41.516Z weekly 0.8 https://www.thebiointel.com/article/ai-strategic-collaborations-healthcare-biopharma-2026 2026-02-27T08:02:41.516Z weekly 0.8 https://www.thebiointel.com/article/prasad-under-probe-for-promoting-workplace-toxicity-staffers-say 2026-02-27T14:02:16.361Z weekly 0.8 https://www.thebiointel.com/article/generate-biomedicines-400m-ipo-severe-asthma 2026-02-27T20:02:29.707Z weekly 0.8 https://www.thebiointel.com/article/pharma-legal-challenges-cdc-vaccine-schedule 2026-02-27T20:02:29.707Z weekly 0.8 https://www.thebiointel.com/article/cdc-expands-vaccine-advisory-committee-new-members-2026 2026-02-28T02:02:07.025Z weekly 0.8 https://www.thebiointel.com/article/henrietta-lacks-estate-settles-novartis-hela-cells-ethics 2026-02-28T14:02:31.962Z weekly 0.8 https://www.thebiointel.com/article/february-2026-healthcare-executive-moves-analysis 2026-02-28T14:02:31.962Z weekly 0.8 https://www.thebiointel.com/article/atrium-therapeutics-raises-270m-rna-therapies-rare-cardiac-disorders 2026-03-01T20:02:14.470Z weekly 0.8 https://www.thebiointel.com/article/goodrx-launches-employer-program-subsidize-high-cost-brand-medications 2026-03-01T20:02:14.470Z weekly 0.8 https://www.thebiointel.com/article/fda-action-alert-key-delays-obesity-dry-eye-treatments 2026-03-02T08:02:20.711Z weekly 0.8 https://www.thebiointel.com/article/health-gorilla-challenges-epic-lawsuit-interoperability-data-governance 2026-03-02T08:02:20.711Z weekly 0.8 https://www.thebiointel.com/article/ascendis-enters-achondroplasia-arena-fda-approves-first-weekly-drug 2026-03-02T14:02:25.459Z weekly 0.8 https://www.thebiointel.com/article/pharma-industry-trump-era-mfn-deals-end-340b-controversies 2026-03-02T14:02:25.459Z weekly 0.8 https://www.thebiointel.com/article/bioatla-axes-70-percent-staff-exploring-strategic-options 2026-03-02T20:02:19.717Z weekly 0.8 https://www.thebiointel.com/article/uniqure-pursues-phase-3-huntingtons-gene-therapy-fda-challenges 2026-03-02T20:02:19.717Z weekly 0.8 https://www.thebiointel.com/article/ai-startups-roi-reckoning-key-insights-vcs 2026-03-03T02:02:10.129Z weekly 0.8 https://www.thebiointel.com/article/major-health-tech-funding-february-2026 2026-03-03T02:02:10.129Z weekly 0.8 https://www.thebiointel.com/article/north-carolina-next-gen-obesity-drug-production-hotspot 2026-03-03T08:03:01.380Z weekly 0.8 https://www.thebiointel.com/article/navigating-fda-post-leadership-changes-advance-drug-development 2026-03-03T08:03:01.380Z weekly 0.8 https://www.thebiointel.com/article/boehringer-ingelheim-ends-mash-collaboration-ose-mid-stage-data-falls-short 2026-03-03T14:02:27.742Z weekly 0.8 https://www.thebiointel.com/article/fda-lifts-hold-intellia-late-stage-crispr-gene-therapy-trials 2026-03-03T14:02:27.742Z weekly 0.8 https://www.thebiointel.com/article/grow-therapy-raises-150m-expand-employer-health-system-partnerships 2026-03-04T02:02:18.965Z weekly 0.8 https://www.thebiointel.com/article/moderna-roivant-settlement-2-25-billion-mrna-vaccine-patent 2026-03-04T02:02:18.965Z weekly 0.8 https://www.thebiointel.com/article/the-job-market-may-be-warming-what-does-that-mean-for-you 2026-03-04T08:02:41.547Z weekly 0.8 https://www.thebiointel.com/article/keytruda-hangs-on-to-best-seller-crown-as-glp-1s-gain-ground 2026-03-04T08:02:41.547Z weekly 0.8 https://www.thebiointel.com/article/teva-blackstone-400m-sanofi-partnered-inflammatory-drug 2026-03-04T14:02:12.181Z weekly 0.8 https://www.thebiointel.com/article/mount-sinai-anthem-contract-dispute-ends-network-affiliation 2026-03-05T02:02:17.845Z weekly 0.8 https://www.thebiointel.com/article/glp-1-drugs-addiction-harm-reduction-study 2026-03-05T02:02:17.845Z weekly 0.8 https://www.thebiointel.com/article/new-mystery-epstein-involvement-harvard-genetics-study 2026-03-05T08:02:02.085Z weekly 0.8 https://www.thebiointel.com/article/fda-acting-cder-director-tracy-beth-hoeg-recruitment-antidepressant-skepticism 2026-03-05T14:02:40.603Z weekly 0.8 https://www.thebiointel.com/article/roche-expands-clinical-trials-south-korea-480m-investment 2026-03-05T14:02:40.603Z weekly 0.8 https://www.thebiointel.com/article/science-corp-raises-230-million-retinal-implant-fda 2026-03-05T20:02:12.163Z weekly 0.8 https://www.thebiointel.com/article/patient-health-data-public-utility-model 2026-03-05T20:02:12.163Z weekly 0.8 https://www.thebiointel.com/article/lilly-employer-connect-flexible-access-obesity-drugs 2026-03-06T02:02:11.114Z weekly 0.8 https://www.thebiointel.com/article/healthcare-ai-startups-pricing-models-completed-tasks 2026-03-06T02:02:11.114Z weekly 0.8 https://www.thebiointel.com/article/alltrna-clinical-acceleration-and-staff-layoffs 2026-03-06T14:02:17.745Z weekly 0.8 https://www.thebiointel.com/article/fda-response-to-uniqure-sham-controlled-trial-debate 2026-03-06T14:02:17.745Z weekly 0.8 https://www.thebiointel.com/article/servier-expands-pediatric-cancer-portfolio-2-5b-day-one-acquisition 2026-03-06T20:02:16.335Z weekly 0.8 https://www.thebiointel.com/article/novo-nordisk-wegovy-ozempic-generic-production-analysis 2026-03-06T20:02:16.335Z weekly 0.8 https://www.thebiointel.com/article/fda-vinay-prasad-departure-cber-chief-controversy 2026-03-07T02:02:13.323Z weekly 0.8 https://www.thebiointel.com/article/google-cloud-healthcare-ai-partnerships-cvs-humana 2026-03-07T02:02:13.323Z weekly 0.8 https://www.thebiointel.com/article/autism-advisory-board-cancels-first-public-meeting 2026-03-07T20:01:36.114Z weekly 0.8 https://www.thebiointel.com/article/preventive-cardiac-care-ai-wearable-tech 2026-03-08T19:01:57.802Z weekly 0.8 https://www.thebiointel.com/article/rural-health-system-scaling-ai-for-point-of-care 2026-03-09T01:02:15.014Z weekly 0.8 https://www.thebiointel.com/article/roche-zealand-pharma-obesity-drug-clinical-trial-results 2026-03-09T01:02:15.014Z weekly 0.8 https://www.thebiointel.com/article/cancer-cells-express-surface-proteins-new-immunotherapy-targets 2026-03-12T19:02:13.731Z weekly 0.8 https://www.thebiointel.com/article/congressional-challenges-pbm-transparency-vertical-integration 2026-03-09T07:02:06.039Z weekly 0.8 https://www.thebiointel.com/article/alfasigma-acquires-gsk-rare-liver-disease-drug-linerixibat-fda-decision 2026-03-09T19:02:28.291Z weekly 0.8 https://www.thebiointel.com/article/fda-advisory-panel-astrazeneca-cancer-drugs-review-nine-months 2026-03-09T19:02:28.291Z weekly 0.8 https://www.thebiointel.com/article/verily-samsung-smartwatch-data-clinical-trials 2026-03-10T01:02:22.716Z weekly 0.8 https://www.thebiointel.com/article/vertex-kidney-disease-drug-iga-nephropathy-trial-success 2026-03-10T01:02:22.716Z weekly 0.8 https://www.thebiointel.com/article/nonprofit-modernizes-manufacturing-clearing-capital-hurdle 2026-03-10T07:02:45.884Z weekly 0.8 https://www.thebiointel.com/article/cell-gene-therapy-manufacturing-market-skyrocket-146b-2032 2026-03-10T13:02:26.746Z weekly 0.8 https://www.thebiointel.com/article/ai-focused-fund-breakout-raises-114m-early-stage-biotech 2026-03-10T13:02:26.746Z weekly 0.8 https://www.thebiointel.com/article/fda-approves-leucovorin-rare-disorder-without-trial-data 2026-03-11T19:02:28.897Z weekly 0.8 https://www.thebiointel.com/article/radial-nonprofit-to-modernize-science-for-ai-era 2026-03-11T19:02:28.897Z weekly 0.8 https://www.thebiointel.com/article/amazon-one-medical-expands-ai-health-assistant 2026-03-12T01:02:14.612Z weekly 0.8 https://www.thebiointel.com/article/vima-therapeutics-parkinsons-disease-expansion-100m-funding 2026-03-12T01:02:14.612Z weekly 0.8 https://www.thebiointel.com/article/hiring-outlook-february-first-yoy-job-increase-2026 2026-03-12T07:01:56.037Z weekly 0.8 https://www.thebiointel.com/article/industry-concerns-fda-data-sharing-cell-gene-therapy 2026-03-12T19:02:13.731Z weekly 0.8 https://www.thebiointel.com/article/hims-hers-novo-nordisk-glp1-collaboration 2026-03-13T01:02:18.585Z weekly 0.8 https://www.thebiointel.com/article/microsoft-copilot-health-ai-chatbot 2026-03-13T01:02:18.585Z weekly 0.8 https://www.thebiointel.com/article/rare-disease-market-growth-small-molecules-2032 2026-03-13T13:02:29.897Z weekly 0.8 https://www.thebiointel.com/article/fda-committee-next-year-flu-shots-advisory 2026-03-13T13:02:29.897Z weekly 0.8 https://www.thebiointel.com/article/cardiovascular-guidelines-statin-treatment-age-30 2026-03-13T19:02:10.460Z weekly 0.8 https://www.thebiointel.com/article/ai-startup-waiv-spinout-precision-cancer-decisions 2026-03-13T19:02:10.460Z weekly 0.8 https://www.thebiointel.com/article/6-things-to-know-stryker-cyberattack 2026-03-14T01:02:42.506Z weekly 0.8 https://www.thebiointel.com/article/virtual-gi-solutions-save-money-improve-patient-symptoms 2026-03-14T07:01:46.737Z weekly 0.8 https://www.thebiointel.com/article/fda-drug-approval-first-for-disease-not-autism 2026-03-15T19:02:07.450Z weekly 0.8 https://www.thebiointel.com/article/epic-health-systems-build-ai-agents-readiness 2026-03-15T19:02:07.450Z weekly 0.8 https://www.thebiointel.com/article/structure-therapeutics-weight-loss-glp1-pill-trial 2026-03-16T13:02:13.458Z weekly 0.8 https://www.thebiointel.com/article/white-house-cracks-down-rfk-jr-vaccine-policies-midterms 2026-03-16T13:02:13.458Z weekly 0.8 https://www.thebiointel.com/article/brain-computer-interface-paralysis-typing-breakthrough 2026-03-16T19:02:15.831Z weekly 0.8 https://www.thebiointel.com/author/alex-morgan 2026-03-15T19:02:07.450Z weekly 0.7 https://www.thebiointel.com/author/sophia-reynolds 2026-03-15T19:02:07.450Z weekly 0.7 https://www.thebiointel.com/author/daniel-cho 2026-03-13T13:02:29.897Z weekly 0.7 https://www.thebiointel.com/author/emily-carter 2026-03-16T13:02:13.458Z weekly 0.7 https://www.thebiointel.com/author/michael-torres 2026-03-13T13:02:29.897Z weekly 0.7 https://www.thebiointel.com/author/priya-nandakumar 2026-03-14T01:02:42.506Z weekly 0.7 https://www.thebiointel.com/author/jonathan-blake 2026-03-16T19:02:15.831Z weekly 0.7 https://www.thebiointel.com/author/biointel-editorial-team 2026-02-02T14:01:44.668Z weekly 0.7